Maximus Inc. (NYSE:MMS) has been assigned a consensus rating of “Hold” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating and four have assigned a hold rating to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $71.33.
A number of analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Wednesday, May 16th. Maxim Group reissued a “hold” rating and set a $69.00 target price (up from $66.00) on shares of Maximus in a research note on Thursday, February 8th. First Analysis raised shares of Maximus from an “equal” rating to a “weight” rating and boosted their target price for the company from $73.00 to $81.00 in a research note on Tuesday, May 8th. Finally, Canaccord Genuity lowered their target price on shares of Maximus from $71.00 to $65.00 and set a “hold” rating for the company in a research note on Friday, February 9th.
In related news, Director Russell A. Beliveau sold 1,000 shares of Maximus stock in a transaction dated Monday, April 2nd. The stock was sold at an average price of $66.55, for a total value of $66,550.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Richard A. Montoni sold 30,000 shares of Maximus stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $67.89, for a total value of $2,036,700.00. The disclosure for this sale can be found here. Insiders sold 41,000 shares of company stock valued at $2,777,450 over the last 90 days. 2.48% of the stock is currently owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in the stock. Meeder Asset Management Inc. raised its holdings in Maximus by 411.7% in the first quarter. Meeder Asset Management Inc. now owns 1,612 shares of the health services provider’s stock worth $108,000 after purchasing an additional 1,297 shares in the last quarter. Ostrum Asset Management bought a new position in Maximus in the first quarter worth about $109,000. We Are One Seven LLC raised its holdings in Maximus by 241.3% in the first quarter. We Are One Seven LLC now owns 2,017 shares of the health services provider’s stock worth $135,000 after purchasing an additional 1,426 shares in the last quarter. Amundi Pioneer Asset Management Inc. bought a new position in Maximus in the fourth quarter worth about $163,000. Finally, Steward Partners Investment Advisory LLC purchased a new stake in shares of Maximus during the fourth quarter worth about $169,000. Hedge funds and other institutional investors own 93.07% of the company’s stock.
NYSE MMS traded up $0.90 on Monday, hitting $63.14. 15,064 shares of the stock were exchanged, compared to its average volume of 460,328. The firm has a market capitalization of $4.06 billion, a price-to-earnings ratio of 20.85, a PEG ratio of 2.40 and a beta of 1.13. Maximus has a 52-week low of $58.58 and a 52-week high of $72.71.
Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, May 10th. The health services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.84 by ($0.02). The firm had revenue of $612.79 million for the quarter, compared to analysts’ expectations of $617.97 million. Maximus had a return on equity of 21.67% and a net margin of 9.15%. The firm’s quarterly revenue was down 1.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.80 earnings per share. research analysts anticipate that Maximus will post 3.24 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 31st. Investors of record on Tuesday, May 15th will be issued a $0.045 dividend. The ex-dividend date of this dividend is Monday, May 14th. This represents a $0.18 annualized dividend and a dividend yield of 0.29%. Maximus’s payout ratio is currently 5.94%.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.